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ABSTRACT
Objective: Our previous coeliac disease genome-wide
association study (GWAS) implicated risk variants in the
human leucocyte antigen (HLA) region and eight novel risk
regions. To identify more coeliac disease loci, we selected
458 single nucleotide polymorphisms (SNPs) that showed
more modest association in the GWAS for genotyping and
analysis in four independent cohorts.
Design: 458 SNPs were assayed in 1682 cases and 3258
controls from three populations (UK, Irish and Dutch). We
combined the results with the original GWAS cohort (767
UK cases and 1422 controls); six SNPs showed
association with p,1610204 and were then genotyped in
an independent Italian coeliac cohort (538 cases and 593
controls).
Results: We identified two novel coeliac disease risk
regions: 6q23.3 (OLIG3-TNFAIP3) and 2p16.1 (REL), both
of which reached genome-wide significance in the
combined analysis of all 2987 cases and 5273 controls
(rs2327832 p = 1.3610208, and rs842647
p = 5.2610207). We investigated the expression of these
genes in the RNA isolated from biopsies and from whole
blood RNA. We did not observe any changes in gene
expression, nor in the correlation of genotype with gene
expression.
Conclusions: Both TNFAIP3 (A20, at the protein level)
and REL are key mediators in the nuclear factor kappa B
(NF-kB) inflammatory signalling pathway. For the first
time, a role for primary heritable variation in this important
biological pathway predisposing to coeliac disease has
been identified. Currently, the HLA risk factors and the 10
established non-HLA risk factors explain ,40% of the
heritability of coeliac disease.
Coeliac disease is a common intestinal inflamma-
tory disorder, characterised by intolerance to diet-
ary gluten protein from wheat, and related
proteins from barley and rye. It is the best
understood human leucocyte antigen (HLA)-
associated disorder. Coeliac disease is rather special
because it shares its pathogenesis with other
autoimmune diseases (such as type 1 diabetes
(T1D) and rheumatoid arthritis (RA)) and with
intestinal inflammatory diseases (such as Crohn’s
disease). Shared genetic risk factors for both coeliac
disease and Crohn’s disease, as well as for coeliac
disease and autoimmunity have been reported.1–4
To search for genetic risk factors, we recently
performed a genome-wide association study
(GWAS) in coeliac disease, followed by replication
of the 1020 most strongly associated single
nucleotide polymorphisms (SNPs) in case–control
cohorts from three populations. These studies led
to the discovery of eight new non-HLA loci.1 5 The
results led to three observations:1
c only three of the confirmed loci were presented
by SNPs located in the top-100 associated
signals in the GWAS, whereas three more
associated SNPs ranked below the top-500,
and one SNP ranked as low as 1004 in the
initial GWAS2
c seven of the eight new loci contained immune-
related genes, four of which are cytokines or
cytokine receptors (IL2/IL21, IL18RAP, IL12A,
and the CCR1/CCR3 cluster locus)3
c four of the new loci (IL2-IL21, IL18RAP, CCR3
and SH2B3) are shared by other autoimmune
and inflammatory disorders1–3 5 6
These three observations prompted us to start a
second replication study in which we followed up
even lower ranking SNPs from our coeliac disease
GWAS, and focused on the involvement of the
immune pathways in the pathogenesis of coeliac
disease (fig 1). We therefore enriched our SNP set
with SNPs that showed association to coeliac
disease in our GWAS and that mapped to the
immune-related genes (mostly interleukins and
their receptors). In addition, we sought shared
autoimmune and inflammatory genes by investi-
gating an overlap between SNPs associated in our
coeliac disease GWAS and to either T1D, RA or
Crohn’s disease in the Wellcome Trust Case
Control Consortium (WTCCC) GWAS data.7
With such a study design we successfully
identified two novel, genome-wide significant,
coeliac disease loci: the intergenic region on
6q23.3 located in the proximity of the TNFAIP3
gene, and 2p16.1, mapping to the second intron of
the REL gene. Both loci indicate an as yet
unrecognised role for the nuclear factor kappa B
(NF-kB) signalling pathway in the pathogenesis of
coeliac disease.
MATERIALS AND METHODS
Subject DNA
DNA was extracted from whole blood, except for
the 1958 cohort control samples, which were
lymphoblastoid cell line DNA, and 374 cases and
176 controls from the UK2 collection, which were
Oragene saliva DNA. Whole-genome amplified
(WGA) blood DNA was used for 194 Irish cases
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and 18 Dutch cases. Genotype cluster theta values for WGA
DNA were similar to blood DNA, for a small fraction of markers
the intensity (R) was lower.
Detailed characteristics of UKGWAS, UK2, Irish, Dutch and
Italian samples are provided in table 1 and previously published
studies.1 5 8 Informed consent was obtained from all subjects.
SNP selection
Three groups of SNPs were selected for the genotyping:
c To follow up our GWAS SNPs were selected with p values
between p.0.000275 and p,0.004 (indicated as SNP-group
1 in table 2 and supplementary data 1; also indicated as
category ‘‘WGAtop2000_noWTCCCassoc’’ in supplemen-
tary data 1) (n = 300).
c SNPs from immune-related genes associated in GWAS with
p,0.05 (indicated as SNP-group 2 in table 2 and supplemen-
tary data 1; also indicated as category ‘‘WGArepli_
ImmuneGenes’’ in supplementary data 1) (n = 55).
c SNPs within the top-3000 coeliac–GWAS ranking
(p,0.009), which showed also association to either type 1
diabetes (T1D), rheumatoid arthritis (RA) or Crohn’s
disease in the WTCCC study with p,0.05 (n = 103). For
calculation of association in the WTCCC cohort we used
imputed genotypes (WTCCC data accessed on 21
November 2007). T1D, RA and Crohn’s cases were
compared to the blood donor WTCCC control cohort
(n = 1500). The 1958 birth cohort was excluded from the
WTCCC analysis, as the majority of these samples over-
lapped with the coeliac disease–GWAS control cohort. This
SNP category is indicated as SNP-group 3 in table 2 and
supplementary data 1; also indicated as category
‘‘WGAtop3000associatedWTCCC’’ in supplementary data 1).
Golden Gate genotyping
Genotyping of all samples was performed following the
manufacturer’s protocol. Genotyping data and clustering was
performed in BeadStudio. Clustering clouds were manually
investigated and adjusted if necessary. Four hundred and fifty-
eight SNPs were included in the genotype analysis. Ten SNPs
with ,95% call rate, because of poor amplification or poor
genotype cloud clustering, were excluded. For the top-6
associated SNPs we investigated clustering in subgroups of
blood, saliva and lymphoblastoid cell line DNAs. All groups
showed similar patterns and comparable theta values. All plates
included one duplicate sample to control for plate swaps. Six
SNPs were out of Hardy–Weinberg equilibrium (p.0.001) and
were excluded from further analysis. In total, 1682 cases and
3258 controls from the three populations (replication cohort 1;
R1) were successfully genotyped for 442 SNPs.
Genotype concordance
A single control DNA sample was included in each 96-well
plate. Genotype concordance for this sample was 99.9% for 45
replicates of 442 SNPs.
Additional genotype quality control
Pairwise comparisons of identity-by-descent were made for all
samples (UK2, Irish and Dutch) using PLINK v1.02. We detected
the same proportion of first-degree relatives as described by
Hunt et al and excluded one sample from each pair of first-
degree relatives from the entire dataset in the current study.1 All
of the top association findings were in Hardy–Weinberg
equilibrium in controls.
Figure 1 Scheme representing the
single nucleotide polymorphisms (SNPs)
selected for the second coeliac genome-
wide association study (GWAS) follow-up
study. WTCCC, Wellcome Trust Case
Control Consortium.
Table 1 Subjects included in our replication study
UKGWAS UK2 Dutch Irish Italian
TotalPhase I – GWAS Replication cohort 1
Replication
cohort 2
Coeliac cases 767 724 514 444 538 2987
Male/female 213/554 169/555 168/346 142/302 132/406
Controls 1422 1398 900 960 593 5273
Male/female 720/702 464/934 550/350 284/676 225/368
TOTAL 2189 2122 1414 1404 1131 8260
GWAS, genome-wide association study.
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Taqman genotyping
Replication cohort 2 (Italian population) was genotyped using
TaqMan probes and primers developed by Applied Biosystems,
on an ABI 7900HT system (Applied Biosystems, Nieuwerkerk a/
d IJssel, the Netherlands). Genotyping was performed following
the manufacturer’s specifications. DNA samples were processed
in 384-well plates and each plate contained eight negative
controls and 16 genotyping controls (four duplicates of four
different samples obtained from the Centre d’Etude du
Polymorphisme Humain (CEPH), Paris, France).
Genotype statistical analysis
Cochran–Mantel–Haenszel allele count x2 association tests
were performed using PLINK9 with four clusters: UKGWAS
(Infinium assay), UK2, IRISH and DUTCH (Golden Gate assay)
collections. All p values are two-tailed. The Cochran–Mantel–
Haenszel allele count x2 association test implicated in SPSS v 15
was used for combined analysis of association of the coeliac
disease cohort (including R2 (Italian) samples), and for analysis
of the combined autoimmune cohort. Using Tarone’s statistic in
SPSS v 15, we tested for heterogeneity of odds ratios between
the different coeliac disease cohorts for the SNPs reported in
table 2. The odds ratios differed significantly between cohorts
(p = 0.007) only for rs1160542. Haplotypes and linkage dis-
equilibrium (LD) blocs were defined and analysed using
Haploview v4.1.10
Intestinal biopsy expression analysis
The duodenal tissue biopsies from 12 healthy controls, 12
untreated coeliac individuals with Marsh III and 12 treated
coeliac individuals with Marsh 0 were collected in RNAlater
(Applied Biosystems/Ambion, Austin, Texas, USA). RNA was
extracted using TRIzol (Invitrogen, Carlsbad, California, USA)
and glass beads, hybridised to HumanRef-8v2 arrays and
analysed as previously described1
Quality control of whole blood PAXgene data
The whole blood PAXgene expression data from 110 unique
coeliac individuals, who were also genotyped in the UKGWAS,
was isolated, hybridized to the Illumina HumanRef-8v2 arrays
and analysed as previously described.11
RESULTS
In a combined analysis of 2449 cases and 4680 controls
(Replication cohort 1 (R1) + GWAS), eight SNPs were associated
with p,1610204. The strongest association signal was
observed for rs2327832 in the OLIG3-TNFAIP3 locus
(pCMH(GWAS+R1) = 6.6610206) (see supplementary data 1
for the results of SNPs per population and combined results).
Six SNPs with p,1610204 (combined GWAS+R1 cohort) were
further genotyped in an independent cohort from Italy,
comprising 538 cases and 593 controls (Replication cohort 2,
R2). We did not genotype rs842639 which was strongly
correlated with rs842647 (r2.0.95), and rs4851274, which failed
the Taqman design. Of these six SNPs, two SNPs were
replicated with associations to the same allele (rs2327832
p = 7.9361025, and rs842647 p = 0.015). rs1160542 in the
AFF3-LONRF2 locus, showed a trend of association to the
opposite allele (p = 0.048). Combining the results from our
GWAS and the two replication cohorts revealed two SNPs
(rs2327832 in the (OLIG3/TNFAIP3 locus and rs842647 in the
REL locus) convincingly associated with coeliac disease with
p = 1.31610208 (odds ratio (OR) = 1.25; confidence intervalTa
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(CI), 1.15 to 1.34) and p = 5.2610207 (OR = 0.84; CI, 0.78 to
0.90), respectively.
In addition, to search for independent association signals in
coeliac disease we performed haplotype analysis with 85 coeliac-
GWAS genotyped SNPs encompassing the OLIG3-TNFAIP3 region
(chromosome 6; bp137851837–138241110, NCBI build36) using
the 767 coeliac cases and 1422 controls included in our GWAS
study. However, none of the other single SNPs or haplotypes was
more strongly associated than rs2327832 (data not shown).
To assess the functional role of the SNPs in two associated
regions, we have investigated the available datasets of the
genome-wide association studies of gene expression.12 13 No
significant effect of the rs2327832 SNP on the OLIG3 or
TNFAIP3, nor of rs842647 on REL, was observed in these
datasets. We also compared the RNA expression profiles of the
OLIG3, TNFAIP3 and REL genes in small-intestine tissue from
healthy controls and from treated and untreated coeliac
patients. None of the genes showed significant differential
expression between the three groups (fig 2A–C).
We correlated cis gene expression in the whole blood samples
from 110 patients with coeliac disease for the OLIG3/TNFAIP3
and rs2327832, as well as REL with rs842647 genotypes. No
significant effect of genotype on gene expression was observed
(fig 2D–F). We also investigated if any other SNP in the 1 Mb
window around each of the two associated SNPs affected gene
expression. No cis effect was observed after correcting for
multiple testing (supplementary data 2).
As one of our aims was to search for shared autoimmune
genes, we also combined our results with those from the
WTCCC GWAS, in particular the results for RA, T1D and
Crohn’s disease compared to the WTCCC blood donor control
group. Two of the variants were found to be associated to T1D
and RA in the WTCCC GWAS: the OLIG3/TNFAIP3*rs2327832
SNP and the AFF3-LONRF2*rs1160542 SNP. All associations in
the WTCCC dataset were observed to the same allele as in our
coeliac disease analysis. Combining the analysis of all inflam-
matory diseases (including coeliac disease, T1D, RA and Crohn’s
disease) rs2327832 in OLIG3/TNFAIP3 (p = 3.78610212) showed
genome-wide significance to immune-related diseases (table 2).
A second SNP, rs1160542 in AFF3-LONRF2, showed modest
association (p = 2.49610206). The AFF3-LONRF2 locus has
previously been nominally replicated in T1D in an independent
case/control (p = 0.02) and a family (p = 0.01) datasets,5 further
strengthening a role for this locus in immune-related disorders.
DISCUSSION
In this study we performed an extensive replication of
moderately associated genetic variants from the GWAS study
in coeliac disease, including variants located in immune-related
genes, and potentially shared autoimmune SNPs. The strongest
association to both coeliac disease and immune-related diseases
was seen for rs2327832, located in a 60 kb block of linkage
disequilibrium (LD) between the OLIG3 and TNFAIP3 genes.
Interestingly, two independent SNPs located in the same LD
block have been previously associated to RA;14 15 one of the RA
associated SNPs (rs6920220) is a perfect proxy (r2 = 1 in CEU
HapMap samples) for rs2327832, the SNP found to be
associated in this study. Recently, the same region was found
to be associated to systemic lupus erythematosus (SLE), another
immune-related disease.16 17 For SLE a second, independent
variant in the TNFAIP3 gene was also found to be associated.16
This indicates the TNFAIP3 gene region as a new, shared
autoimmune locus. The scheme of association among different
autoimmune disorders is presented in fig 3, indicating the
complexity of the association pattern within this locus. Both
the same and different variants are associated to various
autoimmune traits.
TNFAIP3 is an attractive candidate for both inflammatory
and autoimmune pathogenesis. The TNFAIP3 gene product A20
is required for termination of the NF-kB signal mediated by
Figure 2 Expression of candidate genes in small intestine tissue from 12 normal healthy controls (NC), 12 treated coeliac disease patients with a
normal histology of the small intestine, Marsh 0 (M0) and 12 untreated coeliac disease patients with villous atrophy, Marsh III (MIII) (A–C). Correlation
of the rs2327832 genotype with OLIG3 and TNFAIP3 (D,E) and rs842647 genotype with REL expression (F). Expression levels were determined from the
whole blood PAXgene samples from 110 patients with coeliac disease on a gluten-free diet. Bars show group means (A–F).
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innate immune receptors via the de-ubiquitylation of several
NF-kB signalling factors.18 Genetic deficiency of A20 in mice
leads to persistent activation of NF-kB by toll-like receptors,
resulting in multi-organ inflammation, cachexia and neonatal
lethality.19 20 It has been suggested that loss of A20 breaks down
the tolerance of the innate immune system to the commensal
intestinal microflora.21 Although we could not observe an effect
of the associated polymorphisms on expression, this does not
exclude a role for A20 in coeliac disease; there might well be an
effect on the protein level. A20 regulation is rather complex and
can be modified by A20-binding proteins such as ABINs or
TAX1BP1, as well as by post-translational modifications in A20
protein.22 We do not exclude that subtle changes in the protein
structure could lead to modification of A20 activity and,
together with other coeliac-associated risk variants, cause the
disease. Further extensive studies, including fine mapping with
sequencing as well as functional studies (including those on a
protein level), are required to identify the true causal variants.
The second new gene associated with coeliac disease – REL –
is a component of the NF-kB transcription complex that plays a
critical role in promoting immune and inflammatory responses
including through the production of pro-inflammatory cyto-
kines. In another study we observed a moderate association of
REL polymorphisms to ulcerative colitis (p = 0.001), another
intestinal inflammatory disorder,3 suggesting that this gene may
not be unique to coeliac disease pathogenesis. Association of
coeliac disease to both TNFAIP3 and REL points to a role for
innate signalling via NF-kB in the pathology of coeliac disease,
this is a novel finding and has not been reported before.
In this study we have extended the replication of our GWAS
in coeliac disease and searched for genes shared by coeliac
disease and other autoimmune and inflammatory intestinal
disorders. We discovered two new loci associated to coeliac
disease: REL and OLIG3/TNFAIP3. The OLIG3/TNFAIP3 locus
can be considered to be a general immune-related locus as it has
now been associated to four autoimmune disorders (fig 3). This
supports the recent observation that many disease susceptibility
genes contribute to multiple diseases.23 So far, the pathways
associated with coeliac disease have pointed to T cell signalling
and multiple cytokine involvement. Our observation that the
NF-kB signalling pathway is also important adds a new player
to the field.
Figure 3 Location of the signals in the four autoimmune diseases associated to the OLIG3/TNFAIP3 locus. The figure shows the linkage disequilibrium
(LD) block between the OLIG3 and TNFAIP3 genes (NCBIb36, 137 559 184 bp to 138 486 672 bp) associated with multiple diseases. The plot is based
on HapMap CEU data; the D’ plot was generated by Haploview. Single nucleotide polymorphims (SNPs) associated per disease are: SLE*a,b,c and
SLE** (SNPs reported to be associated with SLE (Graham et al16 and Musone et al,17 respectively); RA* and RA** (SNPs associated with RA in Plenge
et al14 and Thomson et al,15 respectively); T1D (SNP associated to T1D in the WTCCC study7); coeliac disease (SNP associated to coeliac disease in the
current study). RA, rheumatoid arthritis; SLE, systemic lupus erthymatosus; T1D, type 1 diabetes; WTCCC, Wellcome Trust Case Control Consortium.
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NF-kB is a transcription complex that plays a key role in
regulating the cellular immune response to infections, stress,
cytokines and other stimuli. Activation of NF-kB in various
inflammatory disorders, including asthma, arthritis and inflam-
matory bowel disease (IBD) has been described.24
Coeliac disease can now be added to the list of complex disorders
that show association to the 6q23 region. This strengthens the
importance of A20 in controlling inflammation in autoimmune
diseases and points to A20 as an attractive candidate for drug
targeting, as suggested recently by Coornaert et al.22
How the newly discovered genes interplay with the
previously identified coeliac loci can only be speculated. On
the one hand, activation of the NF-kB complex leads to
overexpression of inflammatory cytokines and, together with
previously identified cytokines and cytokine receptor genes such
as CCR5, RGS1, IL12A and IL18RAP, this pathway would be
important in fine-tuning the immune response. On the other
hand, the NF-kB pathway may play an independent role in the
innate mechanisms of disease development. Strikingly, genes
involved in the innate immune response have recently been
associated with various autoimmune diseases, suggesting a role
for microbial and viral triggers in disease development. In coeliac
disease an increased frequency of rotaviral infections have been
observed, suggesting that viral infections may, for example,
trigger an innate immune response.25
It is interesting that the knockdown studies of A20 in
dendritic cells show a shift in the subset of activated T cells,
hyperactivation of cytotoxic T lymphocytes and T helper cells,
and suppression of regulatory T cells. This shift results from
enhanced expression of co-stimulatory signals and proinflam-
matory cytokines when inhibiting A2026 and would fit in celiac
disease being a Th1 mediated disease.
These two novel loci can be added to the list of eight known,
non-HLA, genetic risk factors for coeliac disease that have a
smaller risk effect than HLA. Extending the list of common
variants that account for coeliac disease will improve the genetic
prognosis of patients and may help to predict the likelihood of
individuals from the at-risk group developing coeliac disease.
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